Cumulative incidence after day 95.

Cumulative incidence of CMV disease with different levels of pp65 antigenemia during surveillance after day 95 (A), with different levels of PCR positivity (B), and without positive test findings by either method (C). Quantitation is as outlined in “Virologic monitoring.”